Key facts
- This page summarizes Martin D. Madaus's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Jun 2023, 20:50.
Martin D. Madaus - 14 Jun 2023 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)
- Reporting relationship
- Director
- Issuer ticker
- LAB
- Reported as of
- 14 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Jun 2023, 20:50:39 UTC
- Prior SEC filing
- 22 May 2023
- Next SEC filing
- 20 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Martin D. Madaus by Agnieszka Gallagher, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Martin D. Madaus filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 16 Jun 2023.
Change
- Previous filing in this sequence was filed on 22 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LAB
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +26,376
- Change %
- +35%
- Price
- $0.000000
- Shares after
- 102,537
- Date
- 14 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LAB
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +35,380
- Change %
- Price
- $0.000000
- Shares after
- 35,380
- Date
- 14 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,380
- Exercise price
- $2.18
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Consists of Restricted Stock Units. Each Restricted Stock Unit represents the right to receive one share of common stock upon vesting. The Restricted Stock Units vest in full on the earlier to occur of June 14, 2024 and one day prior to the date of the Company's next annual meeting of stockholders subject to the Reporting Person's continued service through the applicable vesting date.
Footnote F2
The Option becomes exercisable in twelve equal monthly increments beginning on July 14, 2023 subject to the Reporting Person's continued service through the applicable vesting date.